# Weichuang Zaisheng

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/weichuang-zaisheng

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Series A (Feb 27, 2026)
- Investors on record: 2

## About

Based in Suzhou, China and founded in 2021, Suzhou MicroPort Regenerative Medicine Technology Co., Ltd., trading as Weichuang Zaisheng, is a high-tech enterprise specializing in the research and development of tissue engineering and regenerative medicine technologies. In February 2026, Weichuang Zaisheng closed Series A funding from new investors Shenzhen Capital Real Estate Fund and Suzhou International Development Venture Capital Holding.

The company is committed to technological innovation in biomaterials, tissue engineering, and regenerative medicine, focusing on key technologies for tissue repair in bone, skin, cartilage, nerve, oral cavity, and sports medicine. Through independent and collaborative research and development, the company has developed several core technologies, aiming to provide efficient and safe tissue repair solutions for clinical use.
The company generates revenue by doing R&D, and providing biomaterials, tissue engineering, regenerative medicine technologies and other related services.
The Series A funding raised in February 2026 will be mainly used for expanding the company's R&D team, upgrading its technology platform, and advancing clinical trials.

## Funding rounds

- Series A, Feb 27, 2026 — Suzhou International Development Venture Capital Holding, Shenzhen Capital Real Estate Fund

## Investors

- Suzhou International Development Venture Capital Holding (https://capitalatlas.ai/funds/suzhou-international-development-venture-capital-holding) — Series A
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A